Is there a place for chemotherapy in the initial treatment for cervical cancer?;LA CHIMIOTHERAPIE A-T-ELLE UNE PLACE LORS DU TRAITEMENT INITIAL DES CANCERS DU COL UTERIN? REVUE DE LA LITTERATURE

Bulletin du Cancer

Volumn 83, Issue 4, 1996, Pages 276-292

  Lhomme C ^a   Schreinerova, M ^a   Delorme, T ^a   Murawa Durand, S ^a   Chazard, M ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

adjuvant; cervical cancer; chemotherapy; concurrent; neoadjuvant

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; IFOSFAMIDE; METHOTREXATE; MITOMYCIN C; VINBLASTINE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; FEMALE; HUMAN; REVIEW; UTERINE CERVIX CANCER; CANCER STAGING; METASTASIS; MORTALITY; MULTIMODALITY CANCER THERAPY; PROGNOSIS; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; SURVIVAL; TREATMENT OUTCOME; UTERINE CERVIX TUMOR;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 0030124137     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Alberts DS, Garcia D, Mason-Liddil N. Cisplatin in advanced cancer of the cervix: an update. Semin Oncol 1991;18 (Suppl 3):11-24
2. Buxton EJ. Experience with bleomycin, ifosfamide, and cisplatin in primary and recurrent cervical cancer. Semin Oncol 1992;19:9-18
3. Buxton EJ, Saunders N, Blackledge G et al. The potential for adjuvant therapy in early-stage cervical cancer. Cancer Chemother Pharmacol 1990;26(Suppl):S17-S21
4. Cardenas J, Olguin A, Figueroa F, Pena J, Becerra F, Huizar R. Neoadjuvant chemotherapy (CT) in cervical carcinoma (CC) PEC + radiotherapy vs radiotherapy: preliminary results [Abstract 732]. Proc Europ Conf Clin Oncol 1991;27(Suppl 2):S124
5. Chang HC, Lai CH, Chen MS, Chao AS, Chen LH, Soong YK. Preliminary results of concurrent radiotherapy and chemotherapy with cis-platinum, vincristine, and bleomycin in bulky advanced cervical carcinoma: a pilot study. Gynecol Oncol 1992;44:182-8
6. Chang HC, Lai CH, Chou PC, Tseng CJ, Chang TC, Hsueh S. Neoadjuvant chemotherapy with cisplatin, vincristine, and bleomycin and radical surgery in early-stage bulky cervical carcinoma. Cancer Chemother Pharmacol 1992;30: 281-5
7. Chauvergne J, Lhommé C, Rohart J et al. Chimiothérapie néoadjuvante des cancers du col utérin aux stades IIb et III. Résultats éloignés d'un essai randomisé pluricentrique portant sur 151 patientes. Bull Cancer 1993;80:1069-79
8. Choo YC, Choy TK, Wong LC, Ma HK. Potentiation of radiotherapy by Cis-dichlorodiammine platinum (II) in advanced cervical carcinoma. Gynecol Oncol 1986;23:94-100
9. Dottino PR, Plaxe SC, Beddoe AM, Johnston C, Cohen CJ. Induction chemotherapy followed by radical surgery in cervical cancer. Gynecol Oncol 1991;40:7-11
10. Drescher CW, Reid GC, Terada K et al. Continuous infusion of low-doses 5-fluorouracil and radiation therapy for poor-prognosis squamous cell carcinoma of the uterine cervix. Gynecol Oncol 1992;44:227-30
11. Fontanelli R, Spatti G, Raspagliesi F, Zunino F, Dire F. A preoperative single course of high-dose cisplatin and bleomycin with glutathione protection in bulky stage IB/II carcinoma of the cervix. Ann Oncol 1992;3:117-21
12. Giaroli A, Sananes C, Sardi JE et al. Lymph node metastases in carcinoma of the cervix uteri: response to neoadjuvant chemotherapy and its impact on survival. Gynecol Oncol 1990;39:34-9
13. Haie C, George M, Pejovic MH et al. Feasability study of an alternating schedule of radiotherapy and chemotherapy in advanced uterine cervical carcinoma. Radiother Oncol 1988;12:121-7
14. Hakes T, Non D, Lewis JL. Adjuvant Cisplatin/Bleomycin for high risk stage IB/IIA cervix carcinoma patients: a pilot study. Proc Am Soc Clin Oncol 1987;6:116
15. Heaton D, Yordan E, Reddy S et al. Treatment of 29 patients with bulky squamous cell carcinoma of the cervix with silmultaneous cisplatin, 5-fluorouracil, and split-course hyperfractionated radiation therapy. Gynecol Oncol 1990;38:323-7
16. Hecquet B, Vennin P, Fournier C, Poissonnier B. Evaluation of the pharmacological benefit and determination of the influencing factors of intraarterial cis-diamminedichloroplatinum administration in patients with uterine cervical cancer. Cancer Res 1987;47:6134-7
17. Hreshchyshyn MM, Aron BS, Boronow RC, Franklin EW, Shingleton HM, Blessing JA. Hydroxyurea or placebo combined with radiation to treat stages III or IV cervical cancer confined to the pelvis. Int J Radiat Oncol Biol Phys 1979; 5:317-22
18. Jones WB. New approaches to high-risk cervical cancer. Cancer 1993;71:1451-9
19. Killackey MA, Boardman L, Carroll DS. Adjuvant chemotherapy and radiation in patients with poor prognostic stage Ib/IIa cervical cancer. Gynecol Oncol 1993;49:377-9
20. Kim DS, Moon H, Hwang YY, Cho SH. Preoperative adjuvant chemotherapy in the treatment of cervical cancer stage Ib, IIa and IIIb with bulky tumor. Gynecol Oncol 1988;29:321-32
21. Kim DS, Moon H, Kim KT, Hwang YY, Cho SH, Kim SR. Two-years survival: preoperative adjuvant chemotherapy in the treatment of cervical cancer stage Ib and II with bulky tumor. Gynecol Oncol 1989;33:225-30
22. Kim DS, Namkoong SE, Baî SN, Lee HY. Comparative study of neoadjuvant chemotherapy followed by surgery versus simple radical surgery in patients with locally advanced cervical cancer. Proceedings of the third meeting Int Gynecol cancer soc; 1991; Cainns: International Gynecologic cancer society:175
23. Kirsten F, Atkinston KH, Coppleson JVM, Elliott PM, Green D, Houghton R. Combination chemotherapy followed by surgery or radiotherapy in patients with locally advanced cervical cancer. Br J Obstet Gynaecol 1987;94:583-8
24. Kohno Y, Iwanari O, Kitao M. Prognostic importance of histologic vascular density in cervical cancer treated with hypertensive intraarterial chemotherapy. Cancer 1993;72: 2394-400
25. Kumar L, Biswal BM, Kumar S, Kriplani A, Rath GK. Randomized phase III study of neo-adjuvant chemotherapy (CT) + radiotherapy vs RT alone in locally advanced cervical cancer (CA CX) [Abstract 819]. Proc ASCO 1994;13
26. Lai CH, Lin TS, Soong YK, Chen HF. Adjuvant chemotherapy after radical hysterectomy for cervical carcinoma. Gynecol Oncol 1989;35:193-8
27. Lejarcegui JA, Cot X, Lailla JM et al. Intraarterial infusion chemotherapy as a primary treatment in cancer of uterine cervix limited to the pelvis. Eur J Gynaecol Oncol 1988; 9:403-9
28. Lhommé C, Michel G, Gerbaulet A et al. Place de la chimiothérapie dans les cancers invasifs du col utérin (stade I et II proximal). In : Journées de chirurgie de l'institut Gustave-Roussy, Paris, 9 décembre 1988
29. Malfetano JH, Keys H. Aggressive multimodality treatment for cervical cancer with paraaortic lymph node metastases. Gynecol Oncol 1991;42:44-7
30. Malviya VK, Deppe G, Kim Y, Gove N. Concurrent radiation therapy, cis-platinum and mitomycin-C in patients with poor prognosis cancer of the cervix: a pilot study. Am J Clinincol 1989;12:434-7
31. e congrès de la Société française d'oncologie gynécologique, Paris, 1992
32. Nagata Y, Ishigati T, Okajima K et al. Transcatheter arterial infusion therapy combined with radical hysterectomy in the treatment of advanced cervical cancer. Cardiovasc. Intervent Radiol 1993;16:14-8
33. Noda K, Takeuchi S, Yajima A et al. Clinical effect of sizofiran combined with irradiation in cervical cancer patients. Jpn J Clin Oncol 1992;22:17-25
34. Omura GA. Current status of chemotherapy for cancer of the cervix. Oncology (Huntingt) 1992;6:27-32,37-8,43
35. Overgaard J, Bentzen SM, Kolstad P et al. Misonidazole combined with radiotherapy in the treatment of carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1989; 16:1069-72
36. Panici PB, Scambia G, Baiocchi G Greggi S, Ragusa G, Gallo A. Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Cancer 1991;67:372-9
37. Park TK, Lee SK, Kim SN et al. Combined chemotherapy and radiation for bulky stages I-II cervical cancer: comparison of concurrent and sequential regimens. Gynecol Oncol 1993;50:196-201
38. Patton TJ, Kavanagh JJ, Delclos L et al. Five year survival in patients given intra-arterial chemotherapy prior to radiotherapy for advanced squamous carcinoma of the cervix and vagina. Gynecol Oncol 1991;42:54-9
39. Petersson F. Annual report on the results of treatment in gynecological cancer. Stockholm : International Federation of gynecology and obstetrics, 1988
40. Potish RA, Twiggs LB. On the lack of demonstrated clinical benefit of neoadjuvant cisplatinum therapy for cervical cancer. Int J Radiat Oncol Biol Phys 1993;27:975-9
41. Rettenmaier MA, Moran MF, Ramsinghani NF et al. Treatment of advanced and recurrent squamous carcinoma of the uterine cervix with constant intraarterial infusion of cisplatin. Cancer 1988;61:1301-3
42. Roberts WS, Kavanagh JJ, Greenberg H et al. Concomitant radiation therapy and chemotherapy in the treatment of advanced squamous carcinoma of the lower female genital tract. Gynecol Oncol 1989;34:183-6
43. Runowicz CD, Wadler S, Rodriguez-Rodriguez L et al. Concomitant cisplatin and radiotherapy in locally advanced cervical carcinoma. Gynecol Oncol 1989;34:395-401
44. Sardi J. Early results of a randomized trial with neoadjuvant chemotherapy in squamous carcinoma cervix uteri. Proceedings of the third meeting of international gynecological cancer society; 1991; Cainns: International Gynecologic cancer society:40
45. Sardi J, Sananes C, Giaroli A et al. Results of a prospective randomized trial with neoadjuvant chemotherapy in stage IB, bulky, squamous carcinoma of the cervix. Gynecol Oncol 1993;49:156-65
46. Sardi J, Sananes C, Giaroli A, Maya G, Di Paola G. Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix uteri. Gynecol Oncol 1990;38:486-93
47. Scarabelli C, Tumolo S, De Paoli A et al. Intermittent pelvic arterial infusion with peptichemio, doxorubicin, and cisplatin for locally advanced and recurrent carcinoma of the uterine cervix. Cancer 1987;60:25-30
48. Shimizu Y, Hasumi K, Masubuchi K. Augmenting effect of sizofiran on the immunofunction of regional lymph nodes in cervical cancer. Cancer 1992;69:1184-94
49. Shiromizu K, Matsuzawa M, Takahashi M, Ishiharo O. Is postoperative radiotherapy and maintenance chemotherapy necessary for carcinoma of the uterine cervix? Br J Obstet Gynecol 1988;95:503-6
50. Sivanesaratnam V, Jayaiakshmi P. Mitomycin C adjuvant chemotherapy after Wertheim's hysterectomy for stage IB cervical cancer. Cancer 1989;64:798-800
51. Souhami L, Gil RA, Allan SE et al. A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIb carcinoma of the cervix. J Clin Oncol 1991;9:970-7
52. Souhami L, Seymour R, Roman TN et al. Weekly Cisplatin plus external beam radiotherapy and high dose rate brachytherapy in patients with locally advanced carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1993;27:871-8
53. Stehman FB, Bundy BN. Carcinoma of the cervix treated with chemotherapy and radiation therapy. Cancer 1993;71: 1697-701
54. Stehman FB, Bundy BN, Thomas G et al. Hydroxyurea versus misonidazole with radiation in cervical carcinoma: long-term follow-up of a Gynecologic Oncology Group trial. J Clin Oncol 1993;11:1523-8
55. Sundfor K, Bertlsen K, Hogberg T, Onsrud M, Trope R, Simonsen E. A randomized multicenter study of induction chemotherapy in patients with squamous cell carcinoma of the uterine cervix stages IIIB-IVA [Abstract 718]. Proc Europ Conf Clin Oncol 1991;27(Suppl 2):S121
56. Symonds RP, Burnett RA, Habeshaw T, Kaye SB, Snee MP. Watson ER. The prognostic value of a response to chemotherapy given before radiotherapy in advanced cancer of cervix. Br J Cancer 1989;59:473-5
57. Tattersall MHN, Ramirez C, Coppleson M. A randomized trial of adjuvant chemotherapy after radical hysterectomy in stage Ib-IIa cervical cancer patients with pelvic lymph nodes metastases. Gynecol Oncol 1992;46:176-81
58. Tattersall MHN, Ramirez C, Dalrymple C, Coppleson M, Elliot P. A randomized trial comparing cisplatin based chemotherapy followed by radiotherapy versus radiotherapy alone in patients with stage IIb-IV cervical cancer. Proceedings of the third meeting of the International Gynecological cancer society, 1991:253
59. Thomas GM. Is neoadjuvant chemotherapy a useful strategy for the treatment of stage IB cervix cancer. Gynecol Oncol 1993;49:153-5
60. Tobias J, Buxton EJ, Blackledge G et al. Neoadjuvant bleomycin, ifosfamide and cisplatin in cervical cancer. Cancer Chemother Pharmacol 1990;26(Suppl):S59-S62
61. Ueki M, Llamura S, Maeda T. Individualization of patients for adjuvant chemotherapy after surgical treatment of cervical cancer. Br J Obstet Gynaecol 1987;94:985-90
62. Vennin P, Hecquet B, Poissonnier B et al. Comparative study of intravenous and intraarterial cis-platinum on intra-tumoral platinum concentration in carcinoma of the cervix. Gynecol Oncol 1989;32:180-3
63. Vermorken JB. Neoadjuvant chemotherapy in cervical cancer: still promising? Ann Oncol 1992;3:97-101
64. Weiner SA, Aristizabal S, Alberts DS, Surwit EA, Deatherage-Deuser K. A phase II trial of mitomycin, vincristine, bleomycin and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinoma. Gynecol Oncol 1988;30:1-6
65. Wertheim MS, Hakes TB, Daghestan I, Nori D, Smith DH, Lewis JL. A pilot study of adjuvant therapy in patients with cervical cancer a high risk of recurrence after radical hysterectomy and pelvic lymphadenectomy. J Clin Oncol 1985;3:912-6
66. Wong LC, Choo YC, Choy D, Sham JST, Ma HK.Long-term follow-up of potentiation of radiotherapy by cis-platinum in advanced carvical cancer. Gynecol Oncol 1989;35:159-63
67. Zanetta G, Landoni F, Colombo A, Pellegrino A, Maneo A, Leventis C. Three-year results after neoadjuvant chemotherapy, radical surgery, and radiotherapy in locally advanced cervical carcinoma.Obstet Oncol 1993;82:447-50